SCHEMBL7594584

SCHEMBL7594584

CCOC(=O)Cn1c(=O)c2c(CNS(=O)(=O)C(F)(F)F)c(-c3ccc(OCOC)cc3)sc2n(Cc2ccccc2SC)c1=O

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GNRHR P30968 14/20 0.36
KCNH2 Q12809 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
MMP12 P39900 1/20 0.32
ALDH1A1 P00352 2/20 0.31
EDNRB P24530 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8193067 0.92 GNRHR (0.36) GNRHRKCNH2KMT2AMMP2MMP9
SCHEMBL7593195 0.92 GNRHR (0.37) GNRHRKCNH2MEN1KMT2AALDH1A1
SCHEMBL7592912 0.92 GNRHR (0.37) GNRHRKCNH2MEN1KMT2AALDH1A1
SCHEMBL7591509 0.90 GNRHR (0.37) GNRHRMEN1KMT2AALDH1A1EDNRB
SCHEMBL7598751 0.90 GNRHR (0.36) GNRHRKCNH2MEN1KMT2AALDH1A1
SCHEMBL7594085 0.90 GNRHR (0.36) GNRHRMEN1KMT2AALDH1A1EDNRB
SCHEMBL7591456 0.87 GNRHR (0.36) GNRHRMEN1KMT2AALDH1A1EDNRB
SCHEMBL7593503 0.86 GNRHR (0.33) GNRHRKCNH2EDNRB
SCHEMBL7596779 0.85 GNRHR (0.43) GNRHRMEN1KMT2AMMP2MMP9
SCHEMBL7594585 0.85 GNRHR (0.41) GNRHRMEN1KMT2AALDH1A1EDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846119-B1 THIENOPYRIMIDINE DERIVATIVES, THEIR PRODUCTION AND USE AS ENDOTHELIN ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-11-13 EP disclosed
US-6140325-A HAS ENDOTHELIN ANTAGONISTIC ACTION; FOR TREATING LIVER HYPOFUNCTION, ACUTE RENAL INSUFFICIENCY, CARDIAC INFARCTION OR LIVER INSUFFICIENCY, VASOCONSTRICTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-10-31 US disclosed